Jpmorgan Chase & CO Dr Reddys Laboratories LTD Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,027,710 shares of RDY stock, worth $83.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,027,710
Previous 2,293,351
162.83%
Holding current value
$83.6 Million
Previous $30.2 Million
178.58%
% of portfolio
0.01%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding RDY
# of Institutions
252Shares Held
94.3MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$181 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$138 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.78MShares$122 Million0.17% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$93.1 Million26.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.35MShares$74.2 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...